The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Cancer statistics, 2026
Open accessAbstract
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population‐based cancer occurrence and outcomes using data collected by central cancer registries (incidence, through 2022) and the National Center for Health Statistics (mortality, through 2023). In 2026, approximately 2,114,850 new cancer cases and 626,140 cancer deaths are projected to occur in the United States. The cancer mortality rate continued to decline through 2023, averting 4.8 million deaths since 1991, largely because of smoking reductions, earlier detection, and improved treatment. These interventions are also evident in rising 5‐year relative survival, which reached a milestone 70% for diagnoses during 2015–2021 overall, 69% for regional‐stage disease, and 35% for distant‐stage (metastatic) disease, up from 63%, 54%, and 17%, respectively, in the mid‐1990s. People with high‐mortality cancers and advanced diagnoses had the largest gains, including increases from 32% to 62% for myeloma, 7% to 22% for liver cancer, 16% to 35% for metastatic melanoma, 8% to 18% for metastatic rectal cancer, 20% to 37% for regional lung cancer, and 2% to 10% for metastatic lung cancer. Nevertheless, lung cancer will cause more deaths in 2026 than second‐ranking colorectal cancer and third‐ranking pancreatic cancer combined. In summary, decades of scientific investment have translated to longer lives for people with even the most fatal cancers. However, continued progress is threatened by proposed federal cuts to cancer research and health insurance, which provides access to life‐saving cancer treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma
Finn, R. S., Qin, S., Ikeda, M., Galle, P. R., Ducreux, M., Kim, T.-Y., Kudo, M., Breder, V., Merle, P., Kaseb, A. O., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1915745 · Cited by 7,470
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
Ang, K. K., Harris, J., Wheeler, R., Weber, R., Rosenthal, D. I., Nguyen-Tân, P. F., Westra, W. H., Chung, C. H., Jordan, R. C., Lu, C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0912217 · Cited by 6,566
Sex differences in immune responses
Klein, S. L., & Flanagan, K. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.90 · Cited by 6,370
Structural racism and health inequities in the USA: evidence and interventions
Bailey, Z. D., Krieger, N., Agénor, M., Graves, J., Linos, N., & Bassett, M. T. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30569-x · Cited by 5,203
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial
de Koning, H. J., van der Aalst, C. M., de Jong, P. A., Scholten, E. T., Nackaerts, K., Heuvelmans, M. A., Lammers, J.-W. J., Weenink, C., Yousaf-Khan, U., Horeweg, N., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1911793 · Cited by 3,624
Dasari, A., Shen, C., Halperin, D., Zhao, B., Zhou, S., Xu, Y., Shih, T., & Yao, J. C. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.0589 · Cited by 3,447
Cancer Disparities by Race/Ethnicity and Socioeconomic Status
Ward, E., Jemal, A., Cokkinides, V., Singh, G. K., Cardinez, C., Ghafoor, A., & Thun, M. (2004) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.54.2.78 · Cited by 1,801
Self-citationThe Effect of Advances in Lung-Cancer Treatment on Population Mortality
Howlader, N., Forjaz, G., Mooradian, M. J., Meza, R., Kong, C. Y., Cronin, K. A., Mariotto, A. B., Lowy, D. R., & Feuer, E. J. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1916623 · Cited by 1,712
Tremelimumab plus durvalumab in unresectable hepatocellular carcinoma
Abou-Alfa, G. K., Lau, G., Kudo, M., Chan, S. L., Kelley, R. K., Furuse, J., Sukeepaisarnjaroen, W., Kang, Y.-K., Van Dao, T., De Toni, E. N., et al. (2022) · NEJM Evidence · doi:10.1056/evidoa2100070 · Cited by 1,576
International Classification of Childhood Cancer, third edition
Steliarova‐Foucher, E., Stiller, C., Lacour, B., & Kaatsch, P. (2005) · Cancer · doi:10.1002/cncr.20910 · Cited by 1,552
Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force, Grossman, D. C., Curry, S. J., Owens, D. K., Bibbins-Domingo, K., Caughey, A. B., Davidson, K. W., Doubeni, C. A., Ebell, M., Epling, J. W., et al. (2018) · JAMA · doi:10.1001/jama.2018.3710 · Cited by 1,436
American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010
Wolf, A. M. D., Wender, R. C., Etzioni, R. B., Thompson, I. M., D'Amico, A. V., Volk, R. J., Brooks, D. D., Dash, C., Guessous, I., Andrews, K., et al. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20066 · Cited by 965
Giaquinto, A. N., Sung, H., Newman, L. A., Freedman, R. A., Smith, R. A., Star, J., Jemal, A., & Siegel, R. L. (2024) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21863 · Cited by 799
Self-citationManagement of Hepatocellular Carcinoma: A Review
Brown, Z. J., Tsilimigras, D. I., Ruff, S. M., Mohseni, A., Kamel, I. R., Cloyd, J. M., & Pawlik, T. M. (2023) · JAMA Surgery · doi:10.1001/jamasurg.2022.7989 · Cited by 763
Singh, G. K., & Jemal, A. (2017) · Journal of Environmental and Public Health · doi:10.1155/2017/2819372 · Cited by 760
Self-citationThe Role of Increasing Detection in the Rising Incidence of Prostate Cancer
Potosky, A. L. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520310046028 · Cited by 674
Moderate Alcohol Intake and Cancer Incidence in Women
Allen, N. E., Beral, V., Casabonne, D., Kan, S. W., Reeves, G. K., Brown, A., Green, J., & Collaborators, O. B. O. T. M. W. S. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn514 · Cited by 600
Survival of Blacks and Whites After a Cancer Diagnosis
Bach, P. B. (2002) · JAMA · doi:10.1001/jama.287.16.2106 · Cited by 513
Kratzer, T. B., Bandi, P., Freedman, N. D., Smith, R. A., Travis, W. D., Jemal, A., & Siegel, R. L. (2024) · Cancer · doi:10.1002/cncr.35128 · Cited by 512
Self-citationProstate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations
Jemal, A., Fedewa, S. A., Ma, J., Siegel, R., Lin, C. C., Brawley, O., & Ward, E. M. (2015) · JAMA · doi:10.1001/jama.2015.14905 · Cited by 469
Self-citationHigher Lung Cancer Incidence in Young Women Than Young Men in the United States
Jemal, A., Miller, K. D., Ma, J., Siegel, R. L., Fedewa, S. A., Islami, F., Devesa, S. S., & Thun, M. J. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1715907 · Cited by 462
Self-citationHealth Insurance Coverage and Health — What the Recent Evidence Tells Us
Sommers, B. D., Gawande, A. A., & Baicker, K. (2017) · New England Journal of Medicine · doi:10.1056/nejmsb1706645 · Cited by 453
Barr, R. D., Ferrari, A., Ries, L., Whelan, J., & Bleyer, W. A. (2016) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2015.4689 · Cited by 451
Are Increasing 5-Year Survival Rates Evidence of Success Against Cancer?
Welch, H. G. (2000) · JAMA · doi:10.1001/jama.283.22.2975 · Cited by 449
Recent Advances in the Treatment of Melanoma
Curti, B. D., & Faries, M. B. (2021) · New England Journal of Medicine · doi:10.1056/nejmra2034861 · Cited by 386
Long-term trends in cancer mortality in the United States, 1930-1998
Wingo, P. A., Cardinez, C. J., Landis, S. H., Greenlee, R. T., Ries, L. A. G., Anderson, R. N., & Thun, M. J. (2003) · Cancer · doi:10.1002/cncr.11380 · Cited by 385
Association of Body Mass Index and Age With Subsequent Breast Cancer Risk in Premenopausal Women
The Premenopausal Breast Cancer Collaborative Group, Schoemaker, M. J., Nichols, H. B., Wright, L. B., Brook, M. N., Jones, M. E., O’Brien, K. M., Adami, H.-O., Baglietto, L., Bernstein, L., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.1771 · Cited by 357
A Systematic Review of Neighborhood Disparities in Point-of-Sale Tobacco Marketing
Lee, J. G. L., Henriksen, L., Rose, S. W., Moreland-Russell, S., & Ribisl, K. M. (2015) · American Journal of Public Health · doi:10.2105/ajph.2015.302777 · Cited by 338
Lynch, E. E., Malcoe, L. H., Laurent, S. E., Richardson, J., Mitchell, B. C., & Meier, H. C. S. (2021) · SSM - Population Health · doi:10.1016/j.ssmph.2021.100793 · Cited by 327
Clarke, M. A., Devesa, S. S., Harvey, S. V., & Wentzensen, N. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.19.00151 · Cited by 299
Cancer Survival: An Overview of Measures, Uses, and Interpretation
Mariotto, A. B., Noone, A.-M., Howlader, N., Cho, H., Keel, G. E., Garshell, J., Woloshin, S., & Schwartz, L. M. (2014) · JNCI Monographs · doi:10.1093/jncimonographs/lgu024 · Cited by 295
Pinsky, P. F., Church, T. R., Izmirlian, G., & Kramer, B. S. (2013) · Cancer · doi:10.1002/cncr.28326 · Cited by 293
Analysis of Breast Cancer Mortality in the US—1975 to 2019
Caswell-Jin, J. L., Sun, L. P., Munoz, D., Lu, Y., Li, Y., Huang, H., Hampton, J. M., Song, J., Jayasekera, J., Schechter, C., et al. (2024) · JAMA · doi:10.1001/jama.2023.25881 · Cited by 284
Impact of Reporting Delay and Reporting Error on Cancer Incidence Rates and Trends
Clegg, L. X. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.20.1537 · Cited by 278
American Cancer Society's report on the status of cancer disparities in the United States, 2021
Islami, F., Guerra, C. E., Minihan, A., Yabroff, K. R., Fedewa, S. A., Sloan, K., Wiedt, T. L., Thomson, B., Siegel, R. L., Nargis, N., et al. (2022) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21703 · Cited by 264
Self-citationOyer, R. A., Hurley, P., Boehmer, L., Bruinooge, S. S., Levit, K., Barrett, N., Benson, A., Bernick, L. A., Byatt, L., Charlot, M., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.22.00754 · Cited by 243
Is There a Recent Epidemic of Women's Drinking? A Critical Review of National Studies
Keyes, K. M., Jager, J., Mal‐Sarkar, T., Patrick, M. E., Rutherford, C., & Hasin, D. (2019) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.14082 · Cited by 233
Principles of Cancer Screening: Lessons From History and Study Design Issues
Croswell, J. M., Ransohoff, D. F., & Kramer, B. S. (2010) · Seminars in Oncology · doi:10.1053/j.seminoncol.2010.05.006 · Cited by 229
Krieger, N., Wright, E., Chen, J. T., Waterman, P. D., Huntley, E. R., & Arcaya, M. (2020) · American Journal of Epidemiology · doi:10.1093/aje/kwaa045 · Cited by 222
Islami, F., Marlow, E. C., Thomson, B., McCullough, M. L., Rumgay, H., Gapstur, S. M., Patel, A. V., Soerjomataram, I., & Jemal, A. (2024) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21858 · Cited by 189
Self-citationJackson, S. S., Marks, M. A., Katki, H. A., Cook, M. B., Hyun, N., Freedman, N. D., Kahle, L. L., Castle, P. E., Graubard, B. I., & Chaturvedi, A. K. (2022) · Cancer · doi:10.1002/cncr.34390 · Cited by 182
Jemal, A., Robbins, A. S., Lin, C. C., Flanders, W. D., DeSantis, C. E., Ward, E. M., & Freedman, R. A. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.73.7932 · Cited by 181
Self-citationGermline Genetic Testing After Cancer Diagnosis
Kurian, A. W., Abrahamse, P., Furgal, A., Ward, K. C., Hamilton, A. S., Hodan, R., Tocco, R., Liu, L., Berek, J. S., Hoang, L., et al. (2023) · JAMA · doi:10.1001/jama.2023.9526 · Cited by 174
Lung Cancer Screening in the US, 2022
Bandi, P., Star, J., Ashad‐Bishop, K. C., Kratzer, T. B., Smith, R. A., & Jemal, A. (2024) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2024.1655 · Cited by 160
Self-citationMoris, D., Martinino, A., Schiltz, S., Allen, P. J., Barbas, A. S., Sudan, D. L., King, L. Y., Berg, C. L., Kim, C., Bashir, M. R., et al. (2025) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.70018 · Cited by 135
Pickle, L. W., Hao, Y., Jemal, A., Zou, Z., Tiwari, R. C., Ward, E., Hachey, M., Howe, H. L., & Feuer, E. J. (2007) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.30 · Cited by 114
Self-citationRecent developments in the treatment of metastatic colorectal cancer
Loree, J. M., & Kopetz, S. (2017) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834017714997 · Cited by 109
Thyroid cancer incidence attributable to overdiagnosis in the United States 1981–2011
O’Grady, T. J., Gates, M. A., & Boscoe, F. P. (2015) · International Journal of Cancer · doi:10.1002/ijc.29634 · Cited by 92
Enduring Cancer Disparities by Persistent Poverty, Rurality, and Race: 1990-1992 to 2014-2018
Moss, J. L., Pinto, C. N., Srinivasan, S., Cronin, K. A., & Croyle, R. T. (2022) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djac038 · Cited by 90
Lawson, M. B., Bissell, M. C. S., Miglioretti, D. L., Eavey, J., Chapman, C. H., Mandelblatt, J. S., Onega, T., Henderson, L. M., Rauscher, G. H., Kerlikowske, K. M., et al. (2022) · JAMA Oncology · doi:10.1001/jamaoncol.2022.1990 · Cited by 84
Interpreting cancer incidence trends: challenges due to the COVID-19 pandemic
Mariotto, A. B., Feuer, E. J., Howlader, N., Chen, H., Negoita, S., & Cronin, K. A. (2023) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djad086 · Cited by 84
A 20-year Follow-up of the International Early Lung Cancer Action Program (I-ELCAP)
Henschke, C. I., Yip, R., Shaham, D., Markowitz, S. B., Deval, J. C., Zulueta, J. J., Seijo, L. M., Aylesworth, C. A., Klingler, K., Andaz, S. K., et al. (2023) · Radiology · doi:10.1148/radiol.231988 · Cited by 84
US Cigarette Smoking Disparities by Race and Ethnicity — Keep Going and Going!
Arrazola, R. A., Griffin, T., Lunsford, N. B., Kittner, D. L., Bammeke, P., Courtney‐Long, E. A., & Armour, B. S. (2023) · Preventing Chronic Disease · doi:10.5888/pcd20.220375 · Cited by 82
Mariotto, A. B., Zou, Z., Johnson, C. J., Scoppa, S., Weir, H. K., & Huang, B. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201034 · Cited by 72
Mortgage Lending Bias and Breast Cancer Survival Among Older Women in the United States
Beyer, K. M. M., Zhou, Y. M., Laud, P. W., McGinley, E. L., Yen, T. W. F., Jankowski, C., Rademacher, N., Namin, S., Kwarteng, J. L., Ponce, S. B., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.21.00112 · Cited by 69
Advances in Locoregional and Systemic Treatments for Hepatocellular Carcinoma
Singal, A. G., Salem, R., Pinato, D. J., & Pillai, A. A. (2025) · Gastroenterology · doi:10.1053/j.gastro.2025.03.047 · Cited by 62
Toward the potential cure of leukemias in the next decade
Kantarjian, H. M., Keating, M. J., & Freireich, E. J. (2018) · Cancer · doi:10.1002/cncr.31669 · Cited by 61
Trends in U.S. women’s binge drinking in middle adulthood by socioeconomic status, 2006–2018
McKetta, S. C., & Keyes, K. M. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108026 · Cited by 57
Cancer in people who identify as lesbian, gay, bisexual, transgender, queer, or gender‐nonconforming
Kratzer, T. B., Star, J., Minihan, A. K., Bandi, P., Scout, N., Gary, M. A., Riddle‐Jones, L., Giaquinto, A. N., Islami, F., Jemal, A., et al. (2024) · Cancer · doi:10.1002/cncr.35355 · Cited by 55
Self-citationNegoita, S., Chen, H., Sanchez, P. V., Sherman, R., Henley, S. J., Siegel, R. L., Sung, H., Scott, S., Benard, V. B., Kohler, B., et al. (2023) · Cancer · doi:10.1002/cncr.35026 · Cited by 54
Self-citationHistorical redlining and breast cancer treatment and survival among older women in the United States
Bikomeye, J. C., Zhou, Y. M., McGinley, E. L., Canales, B., Yen, T. W. F., Tarima, S. S., Ponce, S. B., & Beyer, K. M. M. (2023) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djad034 · Cited by 49
Novel Estimates of Mortality Associated With Poverty in the US
Brady, D., Köhler, U., & Zheng, H. (2023) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2023.0276 · Cited by 46
Madrigal, J. M., Flory, A., Fisher, J. A., Sharp, E. S., Graubard, B. I., Ward, M. H., & Jones, R. R. (2024) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djae001 · Cited by 46
COVID-19 and Rates of Cancer Diagnosis in the US
Burus, T., Lei, F., Huang, B., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.32288 · Cited by 42
Shiels, M. S., Graubard, B. I., McNeel, T. S., Kahle, L., & Freedman, N. D. (2023) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djad256 · Cited by 40
Goel, N., Hernandez, A. E., & Cole, S. W. (2024) · Journal of Clinical Oncology · doi:10.1200/jco.23.02780 · Cited by 35
Breast cancer screening during the COVID-19 pandemic: moving from disparities to health equity
Richman, I. B., Tessier‐Sherman, B., Galusha, D. H., Oladele, C., & Wang, K. (2022) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djac172 · Cited by 33
Accelerated Aging in Survivors of Childhood Cancer—Early Onset and Excess Risk of Chronic Conditions
Yeh, J. M., Ward, Z. J., Stratton, K. L., McMahon, M. V., Taylor, C. S., Armstrong, G. T., Chow, E. J., Hudson, M. M., Morton, L. M., Oeffinger, K. C., et al. (2025) · JAMA Oncology · doi:10.1001/jamaoncol.2025.0236 · Cited by 32
Cancer Screening 3 Years After the Onset of the COVID-19 Pandemic
Star, J., Han, X., Smith, R. A., Schafer, E. J., Jemal, A., & Bandi, P. (2025) · JAMA · doi:10.1001/jama.2025.0902 · Cited by 25
Self-citationAdams, R. S., McKetta, S. C., Jager, J., Stewart, M. T., & Keyes, K. M. (2023) · Addiction · doi:10.1111/add.16262 · Cited by 24
Racial disparities in the screening mammography continuum within a heterogeneous health care system
Ganguly, A., Baker, K. K., Redman, M. W., McClintock, A. H., & Yung, R. L. (2023) · Cancer · doi:10.1002/cncr.34632 · Cited by 24
Racial disparities in diagnostic evaluation of uterine cancer among Medicaid beneficiaries
Xu, X. J., Chen, L., Nuñez-Smith, M., Clark, M. B., & Wright, J. D. (2023) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djad027 · Cited by 22
Nguyen, B. T., Han, X., Jemal, A., & Drope, J. M. (2016) · Preventive Medicine · doi:10.1016/j.ypmed.2016.08.015 · Cited by 20
Self-citationImpact of racial disparities in follow-up and quality of colonoscopy on colorectal cancer outcomes
Alagöz, O., May, F. P., Doubeni, C. A., Fendrick, A. M., Vahdat, V., Estes, C. R., Ellis, T., Limburg, P. J., & Brooks, D. D. (2024) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djae140 · Cited by 18
US cancer deaths prevented due to survival improvements stratified by extent of disease, 2010-2019
Shiels, M. S., Freedman, N. D., Haque, A. T., de González, A. B., Lipkowitz, S., Lowy, D. R., & Pfeiffer, R. M. (2025) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaf192 · Cited by 9
Patient‐reported discordance between care goals and treatment intent in advanced cancer
Shah, M. P., Wenger, N. S., Glaspy, J. A., Hays, R. D., Sudore, R. L., Rahimi, M., Gibbs, L., Anand, S. R., Tseng, C., & Walling, A. M. (2025) · Cancer · doi:10.1002/cncr.35976 · Cited by 7
Karvonen, K. A., Vu, A., Lin, K., Gibbons, J., Mendoza, J. A., Chow, E. J., Winestone, L. E., & Gomez, S. L. (2025) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaf105 · Cited by 5
Leal, T. A. B., & Ramalingam, S. S. (2024) · Cancer · doi:10.1002/cncr.35353 · Cited by 3
Redefining Lung Cancer Therapy — A Long-Awaited Shift in Strategy
Calvo, V. (2025) · New England Journal of Medicine · doi:10.1056/nejme2507130 · Cited by 2
Metadata
- Authors
- Siegel, R. L., Kratzer, T. B., Wagle, N. S., Sung, H., & Jemal, A.
- Venue
- CA: A Cancer Journal for Clinicians
- Publisher
- Wiley
- Published
- 2026-01
- Volume
- 76
- Issue
- 1
- Pages
- e70043-e70043
- ISSN
- 0007-9235 (ISSN-L)
- 1542-4863
- OpenAlex
- W7123452202
- Cited by
- 403
- References
- 79
- FWCI
- 1079.96
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.